Barbexaclone is a prescription medication used to treat seizures in adults and children aged 2 years and older. It belongs to a class of drugs called barbiturates, which work by decreasing abnormal electrical activity in the brain. Common side effects of Barbexaclone include drowsiness, dizziness, nausea, and headache.
Barbexaclone, also known by the brand name Sedalon, was a sedative-hypnotic medication used in the past to treat various conditions, including:
- Insomnia (sleep problems)
- Anxiety
- Preoperative sedation (to reduce anxiety before surgery)
However, Barbexaclone is no longer widely used for several reasons:
- Addiction potential: It was known to be highly addictive and could lead to dependence and withdrawal symptoms upon discontinuation.
- Side effects: It caused various side effects, including drowsiness, dizziness, impaired coordination, and respiratory depression (slowed breathing).
- Safer alternatives: Safer and more effective medications have become available for treating insomnia, anxiety, and preoperative sedation.
Current status:
- Barbexaclone is not recommended for use due to its addiction potential and the availability of safer alternatives.
- It has been discontinued or withdrawn from the market in many countries, including the United States and the United Kingdom.
Anatomical Therapeutic Chemical Classification
N - Nervous system
N03 Antiepileptics
N03A - Antiepileptics
N03AA Barbiturates and derivatives
ATC Code
External Links
Barbexaclone